These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 15063295)

  • 1. Reversal of protein-losing enteropathy with calcium replacement in a patient after Fontan operation.
    Kim SJ; Park IS; Song JY; Lee JY; Shim WS
    Ann Thorac Surg; 2004 Apr; 77(4):1456-7. PubMed ID: 15063295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation.
    Thacker D; Patel A; Dodds K; Goldberg DJ; Semeao E; Rychik J
    Ann Thorac Surg; 2010 Mar; 89(3):837-42. PubMed ID: 20172140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-losing enteropathy after the total cavopulmonary connection: impact of intravenous immunoglobulin.
    Zaupper LB; Nielsen BW; Herlin T
    Congenit Heart Dis; 2011; 6(6):624-9. PubMed ID: 22010984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial pacing: an alternative treatment for protein-losing enteropathy after the Fontan operation.
    Cohen MI; Rhodes LA; Wernovsky G; Gaynor JW; Spray TL; Rychik J
    J Thorac Cardiovasc Surg; 2001 Mar; 121(3):582-3. PubMed ID: 11241095
    [No Abstract]   [Full Text] [Related]  

  • 5. Protein-losing enteropathy after the modified fontan operation: oral prednisone treatment with biopsy and laboratory proved improvement.
    Zellers TM; Brown K
    Pediatr Cardiol; 1996; 17(2):115-7. PubMed ID: 8833498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal bleeding and protein-losing enteropathy after the fontan operation.
    Vyas H; Driscoll DJ; Cetta F; Loftus CG; Connolly HM
    Am J Cardiol; 2006 Sep; 98(5):666-7. PubMed ID: 16923458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-losing enteropathy after the Fontan operation: clinical analysis of nine cases.
    Lin WS; Hwang MS; Chung HT; Chu JJ; Lai MW; Yang JS; Huang SC; Huang JL; Su WJ
    Chang Gung Med J; 2006; 29(5):505-12. PubMed ID: 17214396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of iron deficiency in protein-losing enteropathy following the Fontan procedure.
    Yetman AT; Everitt MD
    Congenit Heart Dis; 2011; 6(4):370-3. PubMed ID: 21392262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-losing enteropathy after Fontan operation: resolution after baffle fenestration.
    Jacobs ML; Rychik J; Byrum CJ; Norwood WI
    Ann Thorac Surg; 1996 Jan; 61(1):206-8. PubMed ID: 8561554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-losing enteropathy after fontan operation: investigations into possible pathophysiologic mechanisms.
    Ostrow AM; Freeze H; Rychik J
    Ann Thorac Surg; 2006 Aug; 82(2):695-700. PubMed ID: 16863787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of transcatheter Fontan fenestration to treat protein losing enteropathy.
    Vyas H; Driscoll DJ; Cabalka AK; Cetta F; Hagler DJ
    Catheter Cardiovasc Interv; 2007 Mar; 69(4):584-9. PubMed ID: 17323361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of protein-losing enteropathy and normalization of mesenteric Doppler flow with sildenafil after Fontan.
    Uzun O; Wong JK; Bhole V; Stumper O
    Ann Thorac Surg; 2006 Dec; 82(6):e39-40. PubMed ID: 17126088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of oral budesonide in adolescents and adults with protein-losing enteropathy after the Fontan operation.
    John AS; Driscoll DJ; Warnes CA; Phillips SD; Cetta F
    Ann Thorac Surg; 2011 Oct; 92(4):1451-6. PubMed ID: 21784410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of octreotide to successfully treat protein-losing enteropathy following the Fontan operation.
    John AS; Phillips SD; Driscoll DJ; Warnes CA; Cetta F
    Congenit Heart Dis; 2011; 6(6):653-6. PubMed ID: 21545466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of heparin in the treatment of protein-losing enteropathy after fontan operation for complex congenital heart disease.
    Kelly AM; Feldt RH; Driscoll DJ; Danielson GK
    Mayo Clin Proc; 1998 Aug; 73(8):777-9. PubMed ID: 9703306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Legionella pneumonia and bacteraemia in association with protein-losing enteropathy after Fontan operation.
    Cheung YF; Leung MP; Yuen KY
    J Infect; 2001 Apr; 42(3):206-7. PubMed ID: 11545554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual treatment for protein losing enteropathy.
    Windram JD; Clift PF; Speakman J; Thorne SA
    Congenit Heart Dis; 2011; 6(3):253-6. PubMed ID: 21418528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-losing enteropathy after Fontan operation.
    Rychik J
    Congenit Heart Dis; 2007; 2(5):288-300. PubMed ID: 18377444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolution of protein-losing enteropathy with low-molecular weight heparin in an adult patient with Fontan palliation.
    Bhagirath KM; Tam JW
    Ann Thorac Surg; 2007 Dec; 84(6):2110-2. PubMed ID: 18036954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral budesonide as a therapy for protein-losing enteropathy in patients having undergone Fontan palliation.
    Turner Z; Lanford L; Webber S
    Congenit Heart Dis; 2012; 7(1):24-30. PubMed ID: 22129195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.